Candesartan cilexetil attenuated cardiac remodeling by improving expression and function of mitofusin 2 in SHR
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference52 articles.
1. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies;Bernardo;Pharmacol Ther,2010
2. Myocardial hypertrophy and its role in heart failure with preserved ejection fraction;Heinzel;J Appl Physiol (1985),2015
3. Cardiovascular risk in relation to a new classification of hypertensive left ventricular geometric abnormalities;De Simone;J Hypertens,2015
4. Second Australian national blood pressure study management committee. Incidence of heart failure in 6083 elderly hypertensive patients: the second Australian national blood pressure study (ANBP2);Sahle;Eur J Heart Fail,2016
5. Is prehypertension really different from normotension and hypertension? A case–control pilot proteomic study in Chinese;Wang;Clin Exp Hypertens,2009
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antihypertensive effects of Pleurospermum lindleyanum aqueous extract in spontaneously hypertensive rats;Journal of Ethnopharmacology;2023-05
2. The Traditional Chinese Medicine Gedan Jiangya Decoction Alleviates Left Ventricular Hypertrophy via Suppressing the Ras/ERK1/2 Signaling Pathway;Evidence-Based Complementary and Alternative Medicine;2022-11-18
3. Mitochondrial Effects of Common Cardiovascular Medications: The Good, the Bad and the Mixed;International Journal of Molecular Sciences;2022-11-07
4. GATA2 promotes human vascular smooth muscle cell proliferation via mitofusin2- mediated Ras/Raf/MEK/ERK signaling pathway. New target in vascular medicine;International Journal of Cardiology;2022-04
5. GATA2 promotes human vascular smooth muscle cell proliferation via mitofusin2-mediated Ras/Raf/MEK/ERK signaling pathway;International Journal of Cardiology;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3